<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2204">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on September 19, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01563107</url>
  </required_header>
  <id_info>
    <org_study_id>VUMC 111633</org_study_id>
    <secondary_id>R01HL071784</secondary_id>
    <nct_id>NCT01563107</nct_id>
  </id_info>
  <brief_title>Dietary Sodium's Effect on Urinary Sodium and Dopamine Excretion in Patients With Postural Tachycardia Syndrome</brief_title>
  <official_title>Dietary Sodium's Effect on Urinary Sodium and Dopamine Excretion in Patients With Postural Tachycardia Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Vanderbilt University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with Postural Tachycardia Syndrome (POTS) may not adequately expand their plasma&#xD;
      volume in response to a high sodium diet. Mechanisms involved in the regulation of plasma&#xD;
      volume, such as the renin-angiotensin-aldosterone system and renal dopamine (DA), may be&#xD;
      impaired in POTS and may respond inappropriately to changes in dietary sodium. The&#xD;
      investigators propose that the changes in urinary sodium and dopamine excretion caused by&#xD;
      consuming low-sodium and high-sodium diets will be different between patients with POTS and&#xD;
      healthy volunteers. The purpose of this study is to determine (1) whether changes in dietary&#xD;
      sodium level appropriately influence sodium excretion in POTS; (2) whether changes in dietary&#xD;
      sodium level appropriately influence DA excretion in POTS; (3) whether a high dietary sodium&#xD;
      level appropriately expands plasma volume in POTS; and (4) whether patients with POTS have&#xD;
      improvements in their orthostatic tachycardia and symptoms as a result of a high dietary&#xD;
      sodium level.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study Day 1&#xD;
&#xD;
        -  Start 150 mEq Na+/day diet (POTS patients as inpatients; healthy control subjects with&#xD;
           Clinical Research Center(CRC)- provided outpatient diet); consume 1.5-2 liters of water&#xD;
           per day&#xD;
&#xD;
        -  Start a 24hour (24hr) urine collection (for sodium (Na+), potassium (K+), creatinine&#xD;
           (Cr), fractionated catecholamines)&#xD;
&#xD;
        -  Blood work&#xD;
&#xD;
      Study Days 2-5&#xD;
&#xD;
        -  Continue 24hr urine collection&#xD;
&#xD;
        -  Start STUDY DIET (10 mEq Na+/day or 300 mEq Na+/day in a random order) after 3 meals of&#xD;
           150 mEq Na+/day are complete; consume 1.5-2 liters of water per day&#xD;
&#xD;
        -  On Day 5, a 24 hr Holter combined ECG monitor and BP monitor will be placed on the&#xD;
           subjects.&#xD;
&#xD;
      Study Day 6&#xD;
&#xD;
        -  Continue STUDY DIET; consume 1.5-2 liters of water per day&#xD;
&#xD;
        -  Remove 24hr Holter combined ECG monitor and BP monitor from subject&#xD;
&#xD;
        -  Continue 24hr urine collection (for Na+, K+, Cr, fractionated catecholamines)&#xD;
&#xD;
        -  Admit to CRC in afternoon (healthy control subjects only, as POTS patients will have&#xD;
           already been admitted). Each subject will spend the night in the CRC and remain supine&#xD;
&#xD;
        -  Nothing by mouth (NPO) after midnight for study next day&#xD;
&#xD;
      Study Day 7&#xD;
&#xD;
        -  Awaken early (~6am) to void (still collecting 24hr urine)&#xD;
&#xD;
        -  Patient returns to bed, IV catheter inserted&#xD;
&#xD;
        -  Posture Study (in morning; between 7-8am ideally)&#xD;
&#xD;
        -  Blood pressure and heart rate will be measured while supine and then while standing for&#xD;
           up to 30 minutes&#xD;
&#xD;
        -  We will draw blood in each body position to measure electrolytes and hormones that&#xD;
           regulate blood pressure and blood volume&#xD;
&#xD;
        -  Subjects will rate symptoms during supine period and at end of stand using Vanderbilt&#xD;
           Orthostatic Symptoms Score (VOSS)&#xD;
&#xD;
        -  Total Blood Volume (DAXOR)- using injection of iodinated I-131 tagged human serum&#xD;
           albumin nominally 25 micro-Ci of radiation blood samples drawn through IV catheter&#xD;
           before injection and for ~30 minutes post-injection (total - 25 ml)&#xD;
&#xD;
        -  This will be done after supine assessment, but before standing the subject up&#xD;
&#xD;
        -  Exercise Capacity Test (in the afternoon) Will estimate maximal oxygen consumption (VO2&#xD;
           max). This test will be conducted on a stationary bicycle. Effort will be gradually&#xD;
           increased while expired air is measured during exhaustive physical work.&#xD;
&#xD;
      All procedures are repeated at least a month later with the 2nd level of dietary salt.&#xD;
      (Randomized to high or low salt in the first phase, the second phase is the remaining level)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">December 2020</completion_date>
  <primary_completion_date type="Actual">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Randomization tables will be used to determine whether the 10 milliequivalents (mEq) sodium/day or 300 mEq sodium/day diet will be consumed first. Both diets will be completed on each subject (randomized crossover study), so all of the study procedures (after screening) will be repeated.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>24hr Urinary Sodium</measure>
    <time_frame>Day 6 am - Day 7 am for each dietary sodium level</time_frame>
    <description>Amount of sodium excreted in urine over 24hr ending on Day 7</description>
  </primary_outcome>
  <primary_outcome>
    <measure>24hr Urinary Dopamine</measure>
    <time_frame>Between Day 6 am - Day 7 am of each dietary sodium level</time_frame>
    <description>Amount of dopamine excreted in urine over 24 hours ending on Day 7</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Plasma Volume</measure>
    <time_frame>after 7 days of each dietary sodium level</time_frame>
    <description>Plasma volume (PV) was determined by the indicator tracer-dilution technique, using the DAXOR Blood Volume Analyzer (BVA)-100 system (DAXOR Corporation), on Day 7 of the low sodium and high sodium dietary interventions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Magnitude of Orthostatic Tachycardia</measure>
    <time_frame>Supine and upright heart rate were measured after 6 days of each dietary sodium level</time_frame>
    <description>Whether the magnitude of the heart rate increase that occurs in patients with POTS when moving from a supine to an upright position is attenuated by a High Sodium diet relative to a Low Sodium diet.&#xD;
Heart rate was assessed after overnight rest and fasting after midnight, following at least 60 minutes of lying quietly. Heart rate was then measured at intervals after subjects had been standing for up to 30 minutes (as tolerated). Differences between supine and standing values are presented for 5 minutes standing (or maximal stand if &lt;5 minutes) since several patients were unable to stand for 10 minutes.&#xD;
Data in POTS patients were compared to that of Healthy Controls.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Upright Symptom Score</measure>
    <time_frame>Upright symptoms were assessed on the 6th day of low or high sodium diet.</time_frame>
    <description>Whether upright symptoms were improved in patients with POTS on a High Sodium diet relative to a Low Sodium diet.&#xD;
Patients were asked to report their standing symptom burden at the end of the Stand portion of the posture study, using the Vanderbilt Orthostatic Symptoms Scale (VOSS). They rated the severity of nine symptoms (palpitations, lightheadedness, mental confusion, blurred vision, shortness of breath, tremulousness, chest discomfort, headache, and nausea) on a scale ranging from a minimum of 0 (reflecting an absence of symptoms) to a maximum score of 10. The sum of the individual symptom scores was used to calculate orthostatic symptom burden for each participant. The lowest possible total score was 0, if a participant scored all 9 questions as 0, and the highest possible score was 90, if a participant scored all 9 questions as 10. Higher scores indicated worse symptoms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary Sodium Following Change in Dietary Sodium Days 1-2</measure>
    <time_frame>24 hour collections ending on Day 2 of each diet phase</time_frame>
    <description>Urinary sodium excretion will be measured every 24 hours as the participant adapts from the 150 mEq Na/day diet to the 10 and 300 mEq Na/day diets.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary Dopamine Following Change in Dietary Sodium Days1-2</measure>
    <time_frame>24 hour collections ending on Day 2 of each dietary sodium phase</time_frame>
    <description>Urinary dopamine excretion will be measured every 24 hours as the participant adapts from the 150 mEq Na/day diet to the 10 and 300 mEq Na/day diets.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary Sodium Following Change in Dietary Sodium Days 2-3</measure>
    <time_frame>24 hour collections ending on Day 3 of each diet phase</time_frame>
    <description>Urinary sodium excretion will be measured every 24 hours as the participant adapts from the 150 mEq Na/day diet to the 10 and 300 mEq Na/day diets.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary Sodium Following Change in Dietary Sodium Days 3-4</measure>
    <time_frame>24 hour collections ending on Day 4 of each diet phase</time_frame>
    <description>Urinary sodium excretion will be measured every 24 hours as the participant adapts from the 150 mEq Na/day diet to the 10 and 300 mEq Na/day diets.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary Sodium Following Change in Dietary Sodium Days 4-5</measure>
    <time_frame>24 hour collections ending on Day 5 of each diet phase</time_frame>
    <description>Urinary sodium excretion will be measured every 24 hours as the participant adapts from the 150 mEq Na/day diet to the 10 and 300 mEq Na/day diets</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary Sodium Following Change in Dietary Sodium Days 5-6</measure>
    <time_frame>24 hour collections ending on Day 6 of each diet phase</time_frame>
    <description>Urinary sodium excretion will be measured every 24 hours as the participant adapts from the 150 mEq Na/day diet to the 10 and 300 mEq Na/day diets.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary Dopamine Following Change in Dietary Sodium Days 2-3</measure>
    <time_frame>24 hour collections ending on Day 3 of each dietary sodium phase</time_frame>
    <description>Urinary dopamine excretion will be measured every 24 hours as the participant adapts from the 150 mEq Na/day diet to the 10 and 300 mEq Na/day diets.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary Dopamine Following Change in Dietary Sodium Days 3-4</measure>
    <time_frame>24 hour collections ending on Day 4 of each dietary sodium phase</time_frame>
    <description>Urinary dopamine excretion will be measured every 24 hours as the participant adapts from the 150 mEq Na/day diet to the 10 and 300 mEq Na/day diets.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary Dopamine Following Change in Dietary Sodium Days 4-5</measure>
    <time_frame>24 hour collections ending on Day 5 of each dietary sodium phase</time_frame>
    <description>Urinary dopamine excretion will be measured every 24 hours as the participant adapts from the 150 mEq Na/day diet to the 10 and 300 mEq Na/day diets.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary Dopamine Following Change in Dietary Sodium Days 5-6</measure>
    <time_frame>24 hour collections ending on Day 6 of each dietary sodium phase</time_frame>
    <description>Urinary dopamine excretion will be measured every 24 hours as the participant adapts from the 150 mEq Na/day diet to the 10 and 300 mEq Na/day diets.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">38</enrollment>
  <condition>Postural Orthostatic Tachycardia Syndrome</condition>
  <arm_group>
    <arm_group_label>High Salt Diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>POTS and healthy controls will be randomly assigned the order of dietary sodium levels. All procedures are performed at both levels. The high sodium diet will provide 300 milliequivalents (mEq) sodium/day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low Salt Diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>POTS and healthy controls will be randomly assigned the order of dietary sodium levels. All procedures are performed at both levels. The low sodium diet will provide 10 mEq sodium/day.</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Plasma Volume</intervention_name>
    <description>Using injection of iodinated I-131 tagged human serum albumin nominally 25 micro-Ci of radiation, blood samples are drawn before and 30 minutes after injection.</description>
    <arm_group_label>High Salt Diet</arm_group_label>
    <arm_group_label>Low Salt Diet</arm_group_label>
    <other_name>DAXOR</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Exercise Capacity Test - Bicycle</intervention_name>
    <description>subjects breathe room air through a mouthpiece and exhale the air into a tube that connects to a machine (metabolic cart) that analyzes carbon dioxide and oxygen content, which allows the investigator to calculate the amount of oxygen they are using under resting and exercise conditions.</description>
    <arm_group_label>High Salt Diet</arm_group_label>
    <arm_group_label>Low Salt Diet</arm_group_label>
    <other_name>VO2 Max (maximal oxygen consumption)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Posture Study</intervention_name>
    <description>Blood pressure and heart rate will be measured while supine and then while standing for up to 30 minutes. Blood will be drawn in each position to measure hormones that regulate blood pressure and blood volume.</description>
    <arm_group_label>High Salt Diet</arm_group_label>
    <arm_group_label>Low Salt Diet</arm_group_label>
    <other_name>Standing Orthostatic Challenge</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Premenopausal patients with POTS and healthy volunteers, 18-50 years old, who are&#xD;
             non-smokers and free of medications with the potential to influence blood pressure&#xD;
&#xD;
          -  Patients diagnosed with postural tachycardia syndrome by the Vanderbilt Autonomic&#xD;
             Dysfunction Center&#xD;
&#xD;
          -  Patients who Increase heart rate â‰¥30 beats/min with position change from supine to&#xD;
             standing (10 minutes)&#xD;
&#xD;
          -  For patients, chronic symptoms consistent with POTS that are worse when upright and&#xD;
             get better with recumbence&#xD;
&#xD;
          -  Only female participants are eligible. Since 80-90% of POTS patients are female, and&#xD;
             there can be differences in measures with the menstrual cycle, including a small&#xD;
             number of males might introduce a significant amount of noise.&#xD;
&#xD;
          -  Able and willing to provide informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Smokers&#xD;
&#xD;
          -  Overt cause for postural tachycardia, i.e., acute dehydration&#xD;
&#xD;
          -  Significant cardiovascular, pulmonary, hepatic, or hematological disease by history or&#xD;
             screening results&#xD;
&#xD;
          -  Positive pregnancy test or breastfeeding&#xD;
&#xD;
          -  Hypertension defined as BP&gt;145/95 off medications when supine or needing&#xD;
             antihypertensive medication&#xD;
&#xD;
          -  Other factors which in the investigator's opinion would prevent the participant from&#xD;
             completing the protocol, including poor compliance during previous studies or an&#xD;
             unpredictable schedule&#xD;
&#xD;
          -  Unable to give informed consent&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alfredo Gamboa, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2021</verification_date>
  <study_first_submitted>March 22, 2012</study_first_submitted>
  <study_first_submitted_qc>March 23, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 26, 2012</study_first_posted>
  <results_first_submitted>November 19, 2021</results_first_submitted>
  <results_first_submitted_qc>December 27, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">January 25, 2022</results_first_posted>
  <last_update_submitted>December 27, 2021</last_update_submitted>
  <last_update_submitted_qc>December 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University Medical Center</investigator_affiliation>
    <investigator_full_name>Alfredo Gamboa</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Orthostatic Intolerance</keyword>
  <keyword>Tachycardia</keyword>
  <keyword>Orthostatic Hypotension</keyword>
  <keyword>Sodium</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Postural Orthostatic Tachycardia Syndrome</mesh_term>
    <mesh_term>Tachycardia</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>February 22, 2011</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/07/NCT01563107/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Healthy Participants: 17 were enrolled and randomized. 1 withdrew due to scheduling. 1 withdrew with migraines in phase 1 (low Na+). 2 withdrew in phase 1 (high Na+): 1 unable to tolerate study diet and another had difficulty cooperating with investigators.&#xD;
Postural Tachycardia Syndrome (POTS): 21 were enrolled and randomized. 6 withdrew before baseline due to age (1), pregnancy (1), prohibited meds (3), and scheduling (1). A 7th patient withdrew during phase 1 (high Na+) due to family illness.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Healthy Participants-Low Na+ Then High Na+</title>
          <description>Healthy controls were randomly assigned the order of dietary sodium (Na+) levels. After baseline labs on Day 0 and 1 day on diet with150 milliequivalent (mEq) sodium/day, participants consumed low Na+ diet (10 mEq sodium/day; LS) for 6 days followed in at least 1 month by baseline labs, 1 day of 150 mEq sodium/day and 6 days of high Na+ diet (300 mEq sodium/day; HS). All procedures were performed at both levels.</description>
        </group>
        <group group_id="P2">
          <title>Healthy Participants-High Na+ Then Low Na+</title>
          <description>Healthy controls were randomly assigned the order of dietary sodium (Na+) levels. After baseline labs on Day 0, and 1 day on diet with 150 milliequivalents (mEq) sodium/day,participants consumed high Na+ diet (300 mEq sodium/day; HS) for 6 days followed in at least 1 month by baseline labs, 1 day of 150 mEq sodium/day and 6 days of low Na+ diet (10 mEq sodium/day; LS). All procedures were performed at both levels.</description>
        </group>
        <group group_id="P3">
          <title>Patients With POTS-Low Na+ Then High Na+</title>
          <description>Patients with POTS were randomly assigned the order of dietary sodium (Na+) levels. After baseline labs on Day 0 and 1 day on diet with 150 mEq sodium/day, participants consumed low Na+ diet (10 mEq sodium/day; LS) for 6 days followed in at least 1 month by baseline labs,1 day of 150 mEq sodium/day and 6 days of high Na+ diet (300 mEq sodium/day; HS). All procedures were performed at both levels.</description>
        </group>
        <group group_id="P4">
          <title>Patients With POTS-High Na+ Then Low Na+</title>
          <description>Patients with POTS were randomly assigned the order of dietary sodium (Na+) levels. After baseline labs on Day 0 and 1 day on diet with150 mEq sodium/day, participants consumed high Na+ diet (300 mEq sodium/day; HS) for 6 days followed in at least 1 month by baseline labs, 1 day of 150 mEq sodium/day and 6 days of low Na+ diet (10 mEq sodium/day; LS). All procedures were performed at both levels.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="12">12 Healthy Controls were randomized to receive LS diet followed by HS diet</participants>
                <participants group_id="P2" count="5">5 Healthy Controls were randomized to receive HS diet followed by LS diet</participants>
                <participants group_id="P3" count="10">10 POTS patients were randomized to receive LS diet followed by HS diet</participants>
                <participants group_id="P4" count="11">11 POTS patients were randomized to receive HS diet followed by LS diet</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>Phase 1 Baseline Labs</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="4">1 healthy control was unable to find time to schedule study</participants>
                <participants group_id="P3" count="8">2 patients with POTS did not discontinue medication that was prohibited by protocol.</participants>
                <participants group_id="P4" count="7">1 patient with POTS did not discontinue medication that was prohibited by protocol, 1 patient was unable to find time to schedule the study, 1 was noted to be too old to participate, and 1 became pregnant between enrollment and the start of phase 1.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>Phase 1-150 mEq Sodium/Day</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Phase 1-start Low Sodium or High Sodium Diet</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Phase 1-finish</title>
              <participants_list>
                <participants group_id="P1" count="11">1 healthy control withdrew with migraines during phase 1 (low Na+).</participants>
                <participants group_id="P2" count="2">2 healthy controls withdrew during phase 1 (high Na+): 1 unable to tolerate study diet and another with difficulty cooperating with investigators.</participants>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="6">1 patient with POTS withdrew during phase 1 due to a family illness.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>Phase 2-150 mEq Sodium/Day</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Phase 2-start Low Sodium or High Sodium Diet</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Phase 2-finish</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>14 patients with Postural Tachycardia Syndrome (POTS) and 13 Controls underwent testing while on a High Sodium Diet and while on a Low Sodium Diet, administered in a randomly assigned order. Baseline data were collected prior to starting the first dietary phase.</population>
      <group_list>
        <group group_id="B1">
          <title>Healthy Participants-Low Na+ Then High Na+</title>
          <description>Healthy controls were randomly assigned the order of dietary sodium (Na+) levels. After 1 day on diet with 150 mEq sodium/day, participants consumed low Na+ diet (10 mEq sodium/day; LS) for 6 days followed in at least 1 month by 1 day of 150 mEq sodium/day and 6 days of high Na+ diet (300 mEq sodium/day; HS). All procedures were performed at both levels</description>
        </group>
        <group group_id="B2">
          <title>HealthyParticipants-HighNa+ Then Low Na+</title>
          <description>Healthy controls were randomly assigned the order of dietary sodium (Na+) levels. After 1 day on diet with 150 mEq sodium/day, participants consumed high Na+ diet (300 mEq sodium/day; HS) for 6 days followed in at least 1 month by 1 day of 150 mEq sodium/day and 6 days of low Na+ diet (10 mEq sodium/day; LS). All procedures were performed at both levels</description>
        </group>
        <group group_id="B3">
          <title>Patients With POTS-Low Na+ Then High Na+</title>
          <description>Patients with POTS were randomly assigned the order of dietary sodium (Na+) levels. After 1 day on diet with 150 mEq sodium/day, participants consumed low Na+ diet (10 mEq sodium/day; LS) for 6 days followed in at least 1 month by 1 day of 150 mEq sodium/day and 6 days of high Na+ diet (300 mEq sodium/day; HS). All procedures were performed at both levels</description>
        </group>
        <group group_id="B4">
          <title>Patients With POTS-High Na+ Then Low Na+</title>
          <description>Patients with POTS were randomly assigned the order of dietary sodium (Na+) levels. After 1 day on diet with 150 mEq sodium/day, participants consumed high Na+ diet (300 mEq sodium/day; HS) for 6 days followed in at least 1 month by 1 day of 150 mEq sodium/day and 6 days of low Na+ diet (10 mEq sodium/day; LS). All procedures were performed at both levels</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="11"/>
            <count group_id="B2" value="2"/>
            <count group_id="B3" value="8"/>
            <count group_id="B4" value="6"/>
            <count group_id="B5" value="27"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31" spread="6"/>
                    <measurement group_id="B2" value="35" spread="10"/>
                    <measurement group_id="B3" value="36" spread="9"/>
                    <measurement group_id="B4" value="32" spread="6"/>
                    <measurement group_id="B5" value="33" spread="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="6"/>
                    <measurement group_id="B5" value="27"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="5"/>
                    <measurement group_id="B5" value="25"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="6"/>
                    <measurement group_id="B5" value="25"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="6"/>
                    <measurement group_id="B5" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>24hr Urinary Sodium</title>
        <description>Amount of sodium excreted in urine over 24hr ending on Day 7</description>
        <time_frame>Day 6 am - Day 7 am for each dietary sodium level</time_frame>
        <population>24hr urine samples ending on Day 7 were collected for 13 healthy controls and 14 patients with POTS</population>
        <group_list>
          <group group_id="O1">
            <title>Healthy Participants Who Consumed Low Sodium Diet as Intervention A or Intervention B</title>
            <description>Healthy controls were randomly assigned the order of dietary sodium levels. All procedures were performed at both levels. Results below were after the low sodium diet. Urine was collected daily for a 24hr period ending at approximately 8am. These results are for the final urine collection which ended on Day 7.</description>
          </group>
          <group group_id="O2">
            <title>Healthy Participants Who Consumed High Sodium Diet as Intervention A or Intervention B</title>
            <description>Healthy controls were randomly assigned the order of dietary sodium levels. All procedures were performed at both levels. Results below were after the high sodium diet. Urine was collected daily for a 24hr period ending at approximately 8am. These results are for the final urine collection which ended on Day 7.</description>
          </group>
          <group group_id="O3">
            <title>Postural Tachycardia Syndrome (POTS) Participants Who Consumed Low Sodium Diet.</title>
            <description>Patients with POTS were randomly assigned the order of dietary sodium levels. All procedures were performed at both levels. Results below were after the low sodium diet. Urine was collected daily for a 24hr period ending at approximately 8am. These results are for the final urine collection which ended on Day 7.</description>
          </group>
          <group group_id="O4">
            <title>Postural Tachycardia Syndrome (POTS) Participants Who Consumed High Sodium Diet</title>
            <description>Patients with POTS were randomly assigned the order of dietary sodium levels. All procedures were performed at both levels. Results below were after the high sodium diet. Urine was collected daily for a 24hr period ending at approximately 8am. These results are for the final urine collection which ended on Day 7.</description>
          </group>
        </group_list>
        <measure>
          <title>24hr Urinary Sodium</title>
          <description>Amount of sodium excreted in urine over 24hr ending on Day 7</description>
          <population>24hr urine samples ending on Day 7 were collected for 13 healthy controls and 14 patients with POTS</population>
          <units>milliequivalents</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
                <count group_id="O3" value="14"/>
                <count group_id="O4" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.8" lower_limit="12" upper_limit="26.6"/>
                    <measurement group_id="O2" value="280" lower_limit="232" upper_limit="306"/>
                    <measurement group_id="O3" value="14.7" lower_limit="10.8" upper_limit="22.6"/>
                    <measurement group_id="O4" value="245" lower_limit="189" upper_limit="264"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>24hr Urinary Dopamine</title>
        <description>Amount of dopamine excreted in urine over 24 hours ending on Day 7</description>
        <time_frame>Between Day 6 am - Day 7 am of each dietary sodium level</time_frame>
        <population>24hr urine samples ending on Day 7 were collected for 13 healthy controls and 14 patients with POTS</population>
        <group_list>
          <group group_id="O1">
            <title>Healthy Participants Who Consumed Low Sodium Diet as Intervention A or Intervention B</title>
            <description>Healthy controls were randomly assigned the order of dietary sodium levels. All procedures were performed at both levels. Results below were after the low sodium diet. Urine was collected daily for a 24hr period ending at approximately 8am. These results are for the final urine collection which ended on Day 7.</description>
          </group>
          <group group_id="O2">
            <title>Healthy Participants Who Consumed High Sodium Diet as Intervention A or Intervention B</title>
            <description>Healthy controls were randomly assigned the order of dietary sodium levels. All procedures were performed at both levels. Results below were after the high sodium diet. Urine was collected daily for a 24hr period ending at approximately 8am. These results are for the final urine collection which ended on Day 7.</description>
          </group>
          <group group_id="O3">
            <title>Postural Tachycardia Syndrome (POTS) Participants Who Consumed Low Sodium Diet.</title>
            <description>Patients with POTS were randomly assigned the order of dietary sodium levels. All procedures were performed at both levels. Results below were after the low sodium diet. Urine was collected daily for a 24hr period ending at approximately 8am. These results are for the final urine collection which ended on Day 7.</description>
          </group>
          <group group_id="O4">
            <title>Postural Tachycardia Syndrome (POTS) Participants Who Consumed High Sodium Diet</title>
            <description>Patients with POTS were randomly assigned the order of dietary sodium levels. All procedures were performed at both levels. Results below were after the high sodium diet. Urine was collected daily for a 24hr period ending at approximately 8am. These results are for the final urine collection which ended on Day 7.</description>
          </group>
        </group_list>
        <measure>
          <title>24hr Urinary Dopamine</title>
          <description>Amount of dopamine excreted in urine over 24 hours ending on Day 7</description>
          <population>24hr urine samples ending on Day 7 were collected for 13 healthy controls and 14 patients with POTS</population>
          <units>micrograms</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
                <count group_id="O3" value="14"/>
                <count group_id="O4" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="223" lower_limit="179" upper_limit="256"/>
                    <measurement group_id="O2" value="236" lower_limit="177" upper_limit="289"/>
                    <measurement group_id="O3" value="202" lower_limit="150" upper_limit="258"/>
                    <measurement group_id="O4" value="205" lower_limit="171" upper_limit="229"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Plasma Volume</title>
        <description>Plasma volume (PV) was determined by the indicator tracer-dilution technique, using the DAXOR Blood Volume Analyzer (BVA)-100 system (DAXOR Corporation), on Day 7 of the low sodium and high sodium dietary interventions.</description>
        <time_frame>after 7 days of each dietary sodium level</time_frame>
        <population>No data analysis for 1 healthy control who had poor venous access on Day 7 of the high sodium diet.</population>
        <group_list>
          <group group_id="O1">
            <title>Healthy Participants Who Consumed Low Sodium Diet as Intervention A or Intervention B</title>
            <description>Healthy controls were randomly assigned the order of dietary sodium levels. All procedures were performed at both levels. Results below were after the low sodium diet.&#xD;
Plasma Volume: Using injection of iodinated I-131 tagged human serum albumin, blood samples were drawn before and 30 minutes after injection on Day 7 of the diet.</description>
          </group>
          <group group_id="O2">
            <title>Healthy Participants Who Consumed High Sodium Diet as Intervention A or Intervention B</title>
            <description>Healthy controls were randomly assigned the order of dietary sodium levels. All procedures were performed at both levels. Results below were after the high sodium diet.&#xD;
Plasma Volume: Using injection of iodinated I-131 tagged human serum albumin, blood samples were drawn before and 30 minutes after injection on Day 7 of the diet.</description>
          </group>
          <group group_id="O3">
            <title>Postural Tachycardia Syndrome (POTS) Participants Who Consumed Low Sodium Diet.</title>
            <description>Patients with POTS were randomly assigned the order of dietary sodium levels. All procedures were performed at both levels. Results below were after the low sodium diet.&#xD;
Plasma Volume: Using injection of iodinated I-131 tagged human serum albumin, blood samples were drawn before and 30 minutes after injection on Day 7 of the diet.</description>
          </group>
          <group group_id="O4">
            <title>Postural Tachycardia Syndrome (POTS) Participants Who Consumed High Sodium Diet</title>
            <description>Patients with POTS were randomly assigned the order of dietary sodium levels. All procedures were performed at both levels. Results below were after the high sodium diet.&#xD;
Plasma Volume: Using injection of iodinated I-131 tagged human serum albumin, blood samples were drawn before and 30 minutes after injection on Day 7 of the diet.</description>
          </group>
        </group_list>
        <measure>
          <title>Plasma Volume</title>
          <description>Plasma volume (PV) was determined by the indicator tracer-dilution technique, using the DAXOR Blood Volume Analyzer (BVA)-100 system (DAXOR Corporation), on Day 7 of the low sodium and high sodium dietary interventions.</description>
          <population>No data analysis for 1 healthy control who had poor venous access on Day 7 of the high sodium diet.</population>
          <units>mL</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="12"/>
                <count group_id="O3" value="14"/>
                <count group_id="O4" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2805" lower_limit="2445" upper_limit="2949"/>
                    <measurement group_id="O2" value="3032" lower_limit="2620" upper_limit="3482"/>
                    <measurement group_id="O3" value="2362" lower_limit="2161" upper_limit="2715"/>
                    <measurement group_id="O4" value="2633" lower_limit="2468" upper_limit="2961"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Magnitude of Orthostatic Tachycardia</title>
        <description>Whether the magnitude of the heart rate increase that occurs in patients with POTS when moving from a supine to an upright position is attenuated by a High Sodium diet relative to a Low Sodium diet.&#xD;
Heart rate was assessed after overnight rest and fasting after midnight, following at least 60 minutes of lying quietly. Heart rate was then measured at intervals after subjects had been standing for up to 30 minutes (as tolerated). Differences between supine and standing values are presented for 5 minutes standing (or maximal stand if &lt;5 minutes) since several patients were unable to stand for 10 minutes.&#xD;
Data in POTS patients were compared to that of Healthy Controls.</description>
        <time_frame>Supine and upright heart rate were measured after 6 days of each dietary sodium level</time_frame>
        <population>Data is not included for 1 patient with POTS on a Low Sodium diet since that patient was unable to stand for even 1 minute.</population>
        <group_list>
          <group group_id="O1">
            <title>Healthy Participants Who Consumed Low Sodium Diet as Intervention A or Intervention B</title>
            <description>Healthy controls were randomly assigned the order of dietary sodium levels. All procedures were performed at both levels. Results below were after the low sodium diet.&#xD;
Supine and upright heart rate were measured on the 6th day of low sodium diet.</description>
          </group>
          <group group_id="O2">
            <title>Healthy Participants Who Consumed High Sodium Diet as Intervention A or Intervention B</title>
            <description>Healthy controls were randomly assigned the order of dietary sodium levels. All procedures were performed at both levels. Results below were after the high sodium diet.&#xD;
Supine and upright heart rate were measured on the 6th day of high sodium diet.</description>
          </group>
          <group group_id="O3">
            <title>Postural Tachycardia Syndrome (POTS) Participants Who Consumed Low Sodium Diet.</title>
            <description>Patients with POTS were randomly assigned the order of dietary sodium levels. All procedures were performed at both levels. Results below were after the low sodium diet.&#xD;
Supine and upright heart rate were measured on the 6th day of low sodium diet.</description>
          </group>
          <group group_id="O4">
            <title>Postural Tachycardia Syndrome (POTS) Participants Who Consumed High Sodium Diet</title>
            <description>Patients with POTS were randomly assigned the order of dietary sodium levels. All procedures were performed at both levels. Results below were after the high sodium diet.&#xD;
Supine and upright heart rate were measured on the 6th day of high sodium diet.</description>
          </group>
        </group_list>
        <measure>
          <title>Magnitude of Orthostatic Tachycardia</title>
          <description>Whether the magnitude of the heart rate increase that occurs in patients with POTS when moving from a supine to an upright position is attenuated by a High Sodium diet relative to a Low Sodium diet.&#xD;
Heart rate was assessed after overnight rest and fasting after midnight, following at least 60 minutes of lying quietly. Heart rate was then measured at intervals after subjects had been standing for up to 30 minutes (as tolerated). Differences between supine and standing values are presented for 5 minutes standing (or maximal stand if &lt;5 minutes) since several patients were unable to stand for 10 minutes.&#xD;
Data in POTS patients were compared to that of Healthy Controls.</description>
          <population>Data is not included for 1 patient with POTS on a Low Sodium diet since that patient was unable to stand for even 1 minute.</population>
          <units>beats per minute</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
                <count group_id="O3" value="13"/>
                <count group_id="O4" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23" lower_limit="19" upper_limit="36"/>
                    <measurement group_id="O2" value="19" lower_limit="11" upper_limit="32"/>
                    <measurement group_id="O3" value="60" lower_limit="55" upper_limit="64"/>
                    <measurement group_id="O4" value="46" lower_limit="32" upper_limit="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Upright Symptom Score</title>
        <description>Whether upright symptoms were improved in patients with POTS on a High Sodium diet relative to a Low Sodium diet.&#xD;
Patients were asked to report their standing symptom burden at the end of the Stand portion of the posture study, using the Vanderbilt Orthostatic Symptoms Scale (VOSS). They rated the severity of nine symptoms (palpitations, lightheadedness, mental confusion, blurred vision, shortness of breath, tremulousness, chest discomfort, headache, and nausea) on a scale ranging from a minimum of 0 (reflecting an absence of symptoms) to a maximum score of 10. The sum of the individual symptom scores was used to calculate orthostatic symptom burden for each participant. The lowest possible total score was 0, if a participant scored all 9 questions as 0, and the highest possible score was 90, if a participant scored all 9 questions as 10. Higher scores indicated worse symptoms.</description>
        <time_frame>Upright symptoms were assessed on the 6th day of low or high sodium diet.</time_frame>
        <population>Upright symptom scores were inadvertently not obtained for the following number of participants:&#xD;
Healthy Participants on Low Sodium diet: 3 Healthy Participants on High Sodium diet: 2 Patients with POTS on Low Sodium diet: 5 Patients with POTS on High Sodium diet: 6</population>
        <group_list>
          <group group_id="O1">
            <title>Healthy Participants Who Consumed Low Sodium Diet as Intervention A or Intervention B</title>
            <description>Healthy controls were randomly assigned the order of dietary sodium levels. All procedures were performed at both levels. Results below were after the low sodium diet.&#xD;
Upright symptoms were assessed on the 6th day of low sodium diet.</description>
          </group>
          <group group_id="O2">
            <title>Healthy Participants Who Consumed High Sodium Diet as Intervention A or Intervention B</title>
            <description>Healthy controls were randomly assigned the order of dietary sodium levels. All procedures were performed at both levels. Results below were after the high sodium diet.&#xD;
Upright symptoms were assessed on the 6th day of high sodium diet.</description>
          </group>
          <group group_id="O3">
            <title>Postural Tachycardia Syndrome (POTS) Participants Who Consumed Low Sodium Diet.</title>
            <description>Patients with POTS were randomly assigned the order of dietary sodium levels. All procedures were performed at both levels. Results below were after the low sodium diet.&#xD;
Upright symptoms were assessed on the 6th day of low sodium diet.</description>
          </group>
          <group group_id="O4">
            <title>Postural Tachycardia Syndrome (POTS) Participants Who Consumed High Sodium Diet</title>
            <description>Patients with POTS were randomly assigned the order of dietary sodium levels. All procedures were performed at both levels. Results below were after the high sodium diet.&#xD;
Upright symptoms were assessed on the 6th day of high sodium diet.</description>
          </group>
        </group_list>
        <measure>
          <title>Upright Symptom Score</title>
          <description>Whether upright symptoms were improved in patients with POTS on a High Sodium diet relative to a Low Sodium diet.&#xD;
Patients were asked to report their standing symptom burden at the end of the Stand portion of the posture study, using the Vanderbilt Orthostatic Symptoms Scale (VOSS). They rated the severity of nine symptoms (palpitations, lightheadedness, mental confusion, blurred vision, shortness of breath, tremulousness, chest discomfort, headache, and nausea) on a scale ranging from a minimum of 0 (reflecting an absence of symptoms) to a maximum score of 10. The sum of the individual symptom scores was used to calculate orthostatic symptom burden for each participant. The lowest possible total score was 0, if a participant scored all 9 questions as 0, and the highest possible score was 90, if a participant scored all 9 questions as 10. Higher scores indicated worse symptoms.</description>
          <population>Upright symptom scores were inadvertently not obtained for the following number of participants:&#xD;
Healthy Participants on Low Sodium diet: 3 Healthy Participants on High Sodium diet: 2 Patients with POTS on Low Sodium diet: 5 Patients with POTS on High Sodium diet: 6</population>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="11"/>
                <count group_id="O3" value="9"/>
                <count group_id="O4" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="4"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="3"/>
                    <measurement group_id="O3" value="30" lower_limit="18" upper_limit="39"/>
                    <measurement group_id="O4" value="19" lower_limit="10" upper_limit="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Urinary Sodium Following Change in Dietary Sodium Days 1-2</title>
        <description>Urinary sodium excretion will be measured every 24 hours as the participant adapts from the 150 mEq Na/day diet to the 10 and 300 mEq Na/day diets.</description>
        <time_frame>24 hour collections ending on Day 2 of each diet phase</time_frame>
        <population>One healthy control neglected to collect urine during this time interval on low sodium diet, and a urine sample for another healthy control on high sodium diet was inadvertently not analyzed for sodium</population>
        <group_list>
          <group group_id="O1">
            <title>Healthy Participants Who Consumed Low Sodium Diet as Intervention A or Intervention B</title>
            <description>Healthy controls were randomly assigned the order of dietary sodium levels with low sodium or high sodium diet starting after 1 day of 150 mEq sodium/day. All procedures were performed at both levels. Results below were after the low sodium diet. Urine was collected daily for a 24hr period ending at approximately 8am. These results are for the urine collection which ended on Day 2.</description>
          </group>
          <group group_id="O2">
            <title>Healthy Participants Who Consumed High Sodium Diet as Intervention A or Intervention B</title>
            <description>Healthy controls were randomly assigned the order of dietary sodium levels with low sodium or high sodium diet starting after 1 day of 150 mEq sodium/day. . All procedures were performed at both levels. Results below were after the high sodium diet. Urine was collected daily for a 24hr period ending at approximately 8am. These results are for the urine collection which ended on Day 2.</description>
          </group>
          <group group_id="O3">
            <title>Postural Tachycardia Syndrome (POTS) Participants Who Consumed Low Sodium Diet.</title>
            <description>Patients with POTS were randomly assigned the order of dietary sodium levels with low sodium or high sodium diet starting after 1 day of 150 mEq sodium/day. All procedures were performed at both levels. Results below were after the low sodium diet. Urine was collected daily for a 24hr period ending at approximately 8am. These results are for the urine collection which ended on Day 2.</description>
          </group>
          <group group_id="O4">
            <title>Postural Tachycardia Syndrome (POTS) Participants Who Consumed High Sodium Diet</title>
            <description>Patients with POTS were randomly assigned the order of dietary sodium levels with low sodium or high sodium diet starting after 1 day of 150 mEq sodium/day. All procedures were performed at both levels. Results below were after the high sodium diet. Urine was collected daily for a 24hr period ending at approximately 8am. These results are for the urine collection which ended on Day 2.</description>
          </group>
        </group_list>
        <measure>
          <title>Urinary Sodium Following Change in Dietary Sodium Days 1-2</title>
          <description>Urinary sodium excretion will be measured every 24 hours as the participant adapts from the 150 mEq Na/day diet to the 10 and 300 mEq Na/day diets.</description>
          <population>One healthy control neglected to collect urine during this time interval on low sodium diet, and a urine sample for another healthy control on high sodium diet was inadvertently not analyzed for sodium</population>
          <units>milliequivalents</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
                <count group_id="O3" value="14"/>
                <count group_id="O4" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="145" lower_limit="118" upper_limit="183"/>
                    <measurement group_id="O2" value="134" lower_limit="96" upper_limit="178"/>
                    <measurement group_id="O3" value="143" lower_limit="103" upper_limit="171"/>
                    <measurement group_id="O4" value="160" lower_limit="95" upper_limit="180"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Urinary Dopamine Following Change in Dietary Sodium Days1-2</title>
        <description>Urinary dopamine excretion will be measured every 24 hours as the participant adapts from the 150 mEq Na/day diet to the 10 and 300 mEq Na/day diets.</description>
        <time_frame>24 hour collections ending on Day 2 of each dietary sodium phase</time_frame>
        <population>One healthy control neglected to collect urine during this time interval on the low sodium diet</population>
        <group_list>
          <group group_id="O1">
            <title>Healthy Participants Who Consumed Low Sodium Diet as Intervention A or Intervention B</title>
            <description>Healthy controls were randomly assigned the order of dietary sodium levels with low sodium or high sodium diet starting after 1 day of 150 mEq sodium/day. All procedures were performed at both levels. Results below were after the low sodium diet. Urine was collected daily for a 24hr period ending at approximately 8am. These results are for the urine collection which ended on Day 2.</description>
          </group>
          <group group_id="O2">
            <title>Healthy Participants Who Consumed High Sodium Diet as Intervention A or Intervention B</title>
            <description>Healthy controls were randomly assigned the order of dietary sodium levels with low sodium or high sodium diet starting after 1 day of 150 mEq sodium/day. All procedures were performed at both levels. Results below were after the high sodium diet. Urine was collected daily for a 24hr period ending at approximately 8am. These results are for the urine collection which ended on Day 2.</description>
          </group>
          <group group_id="O3">
            <title>Postural Tachycardia Syndrome (POTS) Participants Who Consumed Low Sodium Diet.</title>
            <description>Patients with POTS were randomly assigned the order of dietary sodium with low sodium or high sodium diet starting after 1 day of 150 mEq sodium/day. All procedures were performed at both levels. Results below were after the low sodium diet. Urine was collected daily for a 24hr period ending at approximately 8am. These results are for the urine collection which ended on Day 2.</description>
          </group>
          <group group_id="O4">
            <title>Postural Tachycardia Syndrome (POTS) Participants Who Consumed High Sodium Diet</title>
            <description>Patients with POTS were randomly assigned the order of dietary sodium levels with low sodium or high sodium diet starting after 1 day of 150 mEq sodium/day. All procedures were performed at both levels. Results below were after the high sodium diet. Urine was collected daily for a 24hr period ending at approximately 8am. These results are for the urine collection which ended on Day 2.</description>
          </group>
        </group_list>
        <measure>
          <title>Urinary Dopamine Following Change in Dietary Sodium Days1-2</title>
          <description>Urinary dopamine excretion will be measured every 24 hours as the participant adapts from the 150 mEq Na/day diet to the 10 and 300 mEq Na/day diets.</description>
          <population>One healthy control neglected to collect urine during this time interval on the low sodium diet</population>
          <units>micrograms</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="13"/>
                <count group_id="O3" value="14"/>
                <count group_id="O4" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="228" lower_limit="153" upper_limit="265"/>
                    <measurement group_id="O2" value="200" lower_limit="141" upper_limit="256"/>
                    <measurement group_id="O3" value="207" lower_limit="144" upper_limit="262"/>
                    <measurement group_id="O4" value="202" lower_limit="159" upper_limit="228"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Urinary Sodium Following Change in Dietary Sodium Days 2-3</title>
        <description>Urinary sodium excretion will be measured every 24 hours as the participant adapts from the 150 mEq Na/day diet to the 10 and 300 mEq Na/day diets.</description>
        <time_frame>24 hour collections ending on Day 3 of each diet phase</time_frame>
        <population>24hr urine samples were collected and analyzed for 13 healthy controls and 14 patients with POTS during both the low sodium and high sodium diet phases</population>
        <group_list>
          <group group_id="O1">
            <title>Healthy Participants Who Consumed Low Sodium Diet as Intervention A or Intervention B</title>
            <description>Healthy controls were randomly assigned the order of dietary sodium levels with low sodium or high sodium diet starting after 1 day of 150 mEq sodium/day. All procedures were performed at both levels. Results below were after the low sodium diet.&#xD;
Urine was collected daily for a 24hr period ending at approximately 8am.These results are for the urine collection which ended on Day 3.</description>
          </group>
          <group group_id="O2">
            <title>Healthy Participants Who Consumed High Sodium Diet as Intervention A or Intervention B</title>
            <description>Healthy controls were randomly assigned the order of dietary sodium levels with low sodium or high sodium diet starting after 1 day of 150 mEq sodium/day. All procedures were performed at both levels. Results below were after the high sodium diet.&#xD;
Urine was collected daily for a 24hr period ending at approximately 8am.These results are for the urine collection which ended on Day 3.</description>
          </group>
          <group group_id="O3">
            <title>Postural Tachycardia Syndrome (POTS) Participants Who Consumed Low Sodium Diet.</title>
            <description>Patients with POTS were randomly assigned the order of dietary sodium levels with low sodium or high sodium diet starting after 1 day of 150 mEq sodium/day. All procedures were performed at both levels. Results below were after the low sodium diet.&#xD;
Urine was collected daily for a 24hr period ending at approximately 8am.These results are for the urine collection which ended on Day 3.</description>
          </group>
          <group group_id="O4">
            <title>Postural Tachycardia Syndrome (POTS) Participants Who Consumed High Sodium Diet</title>
            <description>Patients with POTS were randomly assigned the order of dietary sodium levels with low sodium or high sodium diet starting after 1 day of 150 mEq sodium/day. All procedures were performed at both levels. Urine was collected daily for a 24hr period ending at approximately 8am.These results are for the urine collection which ended on Day 3.</description>
          </group>
        </group_list>
        <measure>
          <title>Urinary Sodium Following Change in Dietary Sodium Days 2-3</title>
          <description>Urinary sodium excretion will be measured every 24 hours as the participant adapts from the 150 mEq Na/day diet to the 10 and 300 mEq Na/day diets.</description>
          <population>24hr urine samples were collected and analyzed for 13 healthy controls and 14 patients with POTS during both the low sodium and high sodium diet phases</population>
          <units>milliequivalents</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
                <count group_id="O3" value="14"/>
                <count group_id="O4" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.0" lower_limit="73.1" upper_limit="97.4"/>
                    <measurement group_id="O2" value="199" lower_limit="165" upper_limit="209"/>
                    <measurement group_id="O3" value="70.1" lower_limit="60.2" upper_limit="84.6"/>
                    <measurement group_id="O4" value="154" lower_limit="132" upper_limit="194"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Urinary Sodium Following Change in Dietary Sodium Days 3-4</title>
        <description>Urinary sodium excretion will be measured every 24 hours as the participant adapts from the 150 mEq Na/day diet to the 10 and 300 mEq Na/day diets.</description>
        <time_frame>24 hour collections ending on Day 4 of each diet phase</time_frame>
        <population>24hr urine samples were collected and analyzed for 13 healthy controls and 14 patients with POTS during both the low sodium and high sodium diet phases</population>
        <group_list>
          <group group_id="O1">
            <title>Healthy Participants Who Consumed Low Sodium Diet as Intervention A or Intervention B</title>
            <description>Healthy controls were randomly assigned the order of dietary sodium levels with low sodium or high sodium diet starting after 1 day of 150 mEq sodium/day. All procedures were performed at both levels. Results below were after the low sodium diet.&#xD;
Urine was collected daily for a 24hr period ending at approximately 8am.These results are for the urine collection which ended on Day 4.</description>
          </group>
          <group group_id="O2">
            <title>Healthy Participants Who Consumed High Sodium Diet as Intervention A or Intervention B</title>
            <description>Healthy controls were randomly assigned the order of dietary sodium levels with low sodium or high sodium diet starting after 1 day of 150 mEq sodium/day. All procedures were performed at both levels. Results below were after the high sodium diet.&#xD;
Urine was collected daily for a 24hr period ending at approximately 8am.These results are for the urine collection which ended on Day 4.</description>
          </group>
          <group group_id="O3">
            <title>Postural Tachycardia Syndrome (POTS) Participants Who Consumed Low Sodium Diet.</title>
            <description>Patients with POTS were randomly assigned the order of dietary sodium levels with low sodium or high sodium diet starting after 1 day of 150 mEq sodium/day. All procedures were performed at both levels. Results below were after the low sodium diet.&#xD;
Urine was collected daily for a 24hr period ending at approximately 8am.These results are for the urine collection which ended on Day 4.</description>
          </group>
          <group group_id="O4">
            <title>Postural Tachycardia Syndrome (POTS) Participants Who Consumed High Sodium Diet</title>
            <description>Patients with POTS were randomly assigned the order of dietary sodium levels with low sodium or high sodium diet starting after 1 day of 150 mEq sodium/day. All procedures were performed at both levels. Urine was collected daily for a 24hr period ending at approximately 8am.These results are for the urine collection which ended on Day 4.</description>
          </group>
        </group_list>
        <measure>
          <title>Urinary Sodium Following Change in Dietary Sodium Days 3-4</title>
          <description>Urinary sodium excretion will be measured every 24 hours as the participant adapts from the 150 mEq Na/day diet to the 10 and 300 mEq Na/day diets.</description>
          <population>24hr urine samples were collected and analyzed for 13 healthy controls and 14 patients with POTS during both the low sodium and high sodium diet phases</population>
          <units>milliequivalents</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
                <count group_id="O3" value="14"/>
                <count group_id="O4" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.7" lower_limit="22.6" upper_limit="64.7"/>
                    <measurement group_id="O2" value="230" lower_limit="177" upper_limit="261"/>
                    <measurement group_id="O3" value="28.9" lower_limit="19.4" upper_limit="38.9"/>
                    <measurement group_id="O4" value="222" lower_limit="203" upper_limit="265"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Urinary Sodium Following Change in Dietary Sodium Days 4-5</title>
        <description>Urinary sodium excretion will be measured every 24 hours as the participant adapts from the 150 mEq Na/day diet to the 10 and 300 mEq Na/day diets</description>
        <time_frame>24 hour collections ending on Day 5 of each diet phase</time_frame>
        <population>The urine sample for 1 patient with POTS was collected during this time interval during high sodium diet but it was inadvertently not analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Healthy Participants Who Consumed Low Sodium Diet as Intervention A or Intervention B</title>
            <description>Healthy controls were randomly assigned the order of dietary sodium levels with low sodium or high sodium diet starting after 1 day of 150 mEq sodium/day. All procedures were performed at both levels. Results below were after the low sodium diet.&#xD;
Urine was collected daily for a 24hr period ending at approximately 8am.These results are for the urine collection which ended on Day 5.</description>
          </group>
          <group group_id="O2">
            <title>Healthy Participants Who Consumed High Sodium Diet as Intervention A or Intervention B</title>
            <description>Healthy controls were randomly assigned the order of dietary sodium levels with low sodium or high sodium diet starting after 1 day of 150 mEq sodium/day. All procedures were performed at both levels. Results below were after the high sodium diet.&#xD;
Urine was collected daily for a 24hr period ending at approximately 8am.These results are for the urine collection which ended on Day 5.</description>
          </group>
          <group group_id="O3">
            <title>Postural Tachycardia Syndrome (POTS) Participants Who Consumed Low Sodium Diet.</title>
            <description>Patients with POTS were randomly assigned the order of dietary sodium levels with low sodium or high sodium diet starting after 1 day of 150 mEq sodium/day. All procedures were performed at both levels. Results below were after the low sodium diet.&#xD;
Urine was collected daily for a 24hr period ending at approximately 8am.These results are for the urine collection which ended on Day 5.</description>
          </group>
          <group group_id="O4">
            <title>Postural Tachycardia Syndrome (POTS) Participants Who Consumed High Sodium Diet</title>
            <description>Patients with POTS were randomly assigned the order of dietary sodium levels with low sodium or high sodium diet starting after 1 day of 150 mEq sodium/day. All procedures were performed at both levels. Urine was collected daily for a 24hr period ending at approximately 8am.These results are for the urine collection which ended on Day 5.</description>
          </group>
        </group_list>
        <measure>
          <title>Urinary Sodium Following Change in Dietary Sodium Days 4-5</title>
          <description>Urinary sodium excretion will be measured every 24 hours as the participant adapts from the 150 mEq Na/day diet to the 10 and 300 mEq Na/day diets</description>
          <population>The urine sample for 1 patient with POTS was collected during this time interval during high sodium diet but it was inadvertently not analyzed.</population>
          <units>milliequivalents</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
                <count group_id="O3" value="14"/>
                <count group_id="O4" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.3" lower_limit="14.1" upper_limit="28.7"/>
                    <measurement group_id="O2" value="216" lower_limit="182" upper_limit="249"/>
                    <measurement group_id="O3" value="21.6" lower_limit="17.6" upper_limit="26.7"/>
                    <measurement group_id="O4" value="264" lower_limit="258" upper_limit="309"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Urinary Sodium Following Change in Dietary Sodium Days 5-6</title>
        <description>Urinary sodium excretion will be measured every 24 hours as the participant adapts from the 150 mEq Na/day diet to the 10 and 300 mEq Na/day diets.</description>
        <time_frame>24 hour collections ending on Day 6 of each diet phase</time_frame>
        <population>24hr urine samples were collected and analyzed for 13 healthy controls and 14 patients with POTS during both the low sodium and high sodium diet phases</population>
        <group_list>
          <group group_id="O1">
            <title>Healthy Participants Who Consumed Low Sodium Diet as Intervention A or Intervention B</title>
            <description>Healthy controls were randomly assigned the order of dietary sodium levels with low sodium or high sodium diet starting after 1 day of 150 mEq sodium/day. All procedures were performed at both levels. Results below were after the low sodium diet.&#xD;
Urine was collected daily for a 24hr period ending at approximately 8am.These results are for the urine collection which ended on Day 6.</description>
          </group>
          <group group_id="O2">
            <title>Healthy Participants Who Consumed High Sodium Diet as Intervention A or Intervention B</title>
            <description>Healthy controls were randomly assigned the order of dietary sodium levels with low sodium or high sodium diet starting after 1 day of 150 mEq sodium/day. All procedures were performed at both levels. Results below were after the high sodium diet.&#xD;
Urine was collected daily for a 24hr period ending at approximately 8am.These results are for the urine collection which ended on Day 6.</description>
          </group>
          <group group_id="O3">
            <title>Postural Tachycardia Syndrome (POTS) Participants Who Consumed Low Sodium Diet.</title>
            <description>Patients with POTS were randomly assigned the order of dietary sodium levels with low sodium or high sodium diet starting after 1 day of 150 mEq sodium/day. All procedures were performed at both levels. Results below were after the low sodium diet.&#xD;
Urine was collected daily for a 24hr period ending at approximately 8am.These results are for the urine collection which ended on Day 6.</description>
          </group>
          <group group_id="O4">
            <title>Postural Tachycardia Syndrome (POTS) Participants Who Consumed High Sodium Diet</title>
            <description>Patients with POTS were randomly assigned the order of dietary sodium levels with low sodium or high sodium diet starting after 1 day of 150 mEq sodium/day. All procedures were performed at both levels. Urine was collected daily for a 24hr period ending at approximately 8am.These results are for the urine collection which ended on Day 6.</description>
          </group>
        </group_list>
        <measure>
          <title>Urinary Sodium Following Change in Dietary Sodium Days 5-6</title>
          <description>Urinary sodium excretion will be measured every 24 hours as the participant adapts from the 150 mEq Na/day diet to the 10 and 300 mEq Na/day diets.</description>
          <population>24hr urine samples were collected and analyzed for 13 healthy controls and 14 patients with POTS during both the low sodium and high sodium diet phases</population>
          <units>milliequivalents</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
                <count group_id="O3" value="14"/>
                <count group_id="O4" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.6" lower_limit="14.6" upper_limit="31.6"/>
                    <measurement group_id="O2" value="260" lower_limit="187" upper_limit="293"/>
                    <measurement group_id="O3" value="18.2" lower_limit="11.6" upper_limit="25.8"/>
                    <measurement group_id="O4" value="242" lower_limit="201" upper_limit="286"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Urinary Dopamine Following Change in Dietary Sodium Days 2-3</title>
        <description>Urinary dopamine excretion will be measured every 24 hours as the participant adapts from the 150 mEq Na/day diet to the 10 and 300 mEq Na/day diets.</description>
        <time_frame>24 hour collections ending on Day 3 of each dietary sodium phase</time_frame>
        <population>The urine sample for 1 healthy control was collected during this interval of the low sodium diet phase, but the sample was inadvertently sent to the wrong lab for analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Healthy Participants Who Consumed Low Sodium Diet as Intervention A or Intervention B</title>
            <description>Healthy controls were randomly assigned the order of dietary sodium levels with low sodium or high sodium diet starting after 1 day of 150 mEq sodium/day. All procedures were performed at both levels. Results below were after the low sodium diet. Urine was collected daily for a 24hr period ending at approximately 8am. These results are for the urine collection which ended on Day 3.</description>
          </group>
          <group group_id="O2">
            <title>Healthy Participants Who Consumed High Sodium Diet as Intervention A or Intervention B</title>
            <description>Healthy controls were randomly assigned the order of dietary sodium levels with low sodium or high sodium diet starting after 1 day of 150 mEq sodium/day. All procedures were performed at both levels. Results below were after the high sodium diet. Urine was collected daily for a 24hr period ending at approximately 8am. These results are for the urine collection which ended on Day 3.</description>
          </group>
          <group group_id="O3">
            <title>Postural Tachycardia Syndrome (POTS) Participants Who Consumed Low Sodium Diet.</title>
            <description>Patients with POTS were randomly assigned the order of dietary sodium levels with low sodium or high sodium diet starting after 1 day of 150 mEq sodium/day. All procedures were performed at both levels. Results below were after the low sodium diet. Urine was collected daily for a 24hr period ending at approximately 8am. These results are for the urine collection which ended on Day 3.</description>
          </group>
          <group group_id="O4">
            <title>Postural Tachycardia Syndrome (POTS) Participants Who Consumed High Sodium Diet</title>
            <description>Patients with POTS were randomly assigned the order of dietary sodium levels with low sodium or high sodium diet starting after 1 day of 150 mEq sodium/day. All procedures were performed at both levels. Results below were after the high sodium diet. Urine was collected daily for a 24hr period ending at approximately 8am. These results are for the urine collection which ended on Day 3.</description>
          </group>
        </group_list>
        <measure>
          <title>Urinary Dopamine Following Change in Dietary Sodium Days 2-3</title>
          <description>Urinary dopamine excretion will be measured every 24 hours as the participant adapts from the 150 mEq Na/day diet to the 10 and 300 mEq Na/day diets.</description>
          <population>The urine sample for 1 healthy control was collected during this interval of the low sodium diet phase, but the sample was inadvertently sent to the wrong lab for analysis</population>
          <units>micrograms</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="13"/>
                <count group_id="O3" value="14"/>
                <count group_id="O4" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="183" lower_limit="138" upper_limit="271"/>
                    <measurement group_id="O2" value="185" lower_limit="126" upper_limit="250"/>
                    <measurement group_id="O3" value="205" lower_limit="158" upper_limit="236"/>
                    <measurement group_id="O4" value="171" lower_limit="144" upper_limit="226"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Urinary Dopamine Following Change in Dietary Sodium Days 3-4</title>
        <description>Urinary dopamine excretion will be measured every 24 hours as the participant adapts from the 150 mEq Na/day diet to the 10 and 300 mEq Na/day diets.</description>
        <time_frame>24 hour collections ending on Day 4 of each dietary sodium phase</time_frame>
        <population>The urine sample for 1 healthy control was collected during this interval of the low sodium diet phase, but the sample was inadvertently sent to the wrong lab for analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Healthy Participants Who Consumed Low Sodium Diet as Intervention A or Intervention B</title>
            <description>Healthy controls were randomly assigned the order of dietary sodium levels with low sodium or high sodium diet starting after 1 day of 150 mEq sodium/day. All procedures were performed at both levels. Results below were after the low sodium diet. Urine was collected daily for a 24hr period ending at approximately 8am. These results are for the urine collection which ended on Day 4.</description>
          </group>
          <group group_id="O2">
            <title>Healthy Participants Who Consumed High Sodium Diet as Intervention A or Intervention B</title>
            <description>Healthy controls were randomly assigned the order of dietary sodium levels with low sodium or high sodium diet starting after 1 day of 150 mEq sodium/day. All procedures were performed at both levels. Results below were after the high sodium diet. Urine was collected daily for a 24hr period ending at approximately 8am. These results are for the urine collection which ended on Day 4.</description>
          </group>
          <group group_id="O3">
            <title>Postural Tachycardia Syndrome (POTS) Participants Who Consumed Low Sodium Diet</title>
            <description>Patients with POTS were randomly assigned the order of dietary sodium levels with low sodium or high sodium diet starting after 1 day of 150 mEq sodium/day. All procedures were performed at both levels. Results below were after the low sodium diet. Urine was collected daily for a 24hr period ending at approximately 8am. These results are for the urine collection which ended on Day 4.</description>
          </group>
          <group group_id="O4">
            <title>Postural Tachycardia Syndrome (POTS) Participants Who Consumed High Sodium Diet.</title>
            <description>Patients with POTS were randomly assigned the order of dietary sodium levels with low sodium or high sodium diet starting after 1 day of 150 mEq sodium/day. All procedures were performed at both levels. Results below were after the high sodium diet. Urine was collected daily for a 24hr period ending at approximately 8am. These results are for the urine collection which ended on Day 4.</description>
          </group>
        </group_list>
        <measure>
          <title>Urinary Dopamine Following Change in Dietary Sodium Days 3-4</title>
          <description>Urinary dopamine excretion will be measured every 24 hours as the participant adapts from the 150 mEq Na/day diet to the 10 and 300 mEq Na/day diets.</description>
          <population>The urine sample for 1 healthy control was collected during this interval of the low sodium diet phase, but the sample was inadvertently sent to the wrong lab for analysis</population>
          <units>micrograms</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="13"/>
                <count group_id="O3" value="14"/>
                <count group_id="O4" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="222" lower_limit="152" upper_limit="259"/>
                    <measurement group_id="O2" value="193" lower_limit="128" upper_limit="244"/>
                    <measurement group_id="O3" value="203" lower_limit="154" upper_limit="235"/>
                    <measurement group_id="O4" value="177" lower_limit="136" upper_limit="211"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Urinary Dopamine Following Change in Dietary Sodium Days 4-5</title>
        <description>Urinary dopamine excretion will be measured every 24 hours as the participant adapts from the 150 mEq Na/day diet to the 10 and 300 mEq Na/day diets.</description>
        <time_frame>24 hour collections ending on Day 5 of each dietary sodium phase</time_frame>
        <population>Urine was collected and analyzed for 13 healthy controls and 14 patients with POTS during this time interval of the low sodium and high sodium diets</population>
        <group_list>
          <group group_id="O1">
            <title>Healthy Participants Who Consumed Low Sodium Diet as Intervention A or Intervention B</title>
            <description>Healthy controls were randomly assigned the order of dietary sodium levels with low sodium or high sodium diet starting after 1 day of 150 mEq sodium/day. All procedures were performed at both levels. Results below were after the low sodium diet. Urine was collected daily for a 24hr period ending at approximately 8am. These results are for the urine collection which ended on Day 5.</description>
          </group>
          <group group_id="O2">
            <title>Healthy Participants Who Consumed High Sodium Diet as Intervention A or Intervention B</title>
            <description>Healthy controls were randomly assigned the order of dietary sodium levels with low sodium or high sodium diet starting after 1 day of 150 mEq sodium/day. All procedures were performed at both levels. Results below were after the high sodium diet. Urine was collected daily for a 24hr period ending at approximately 8am. These results are for the urine collection which ended on Day 5.</description>
          </group>
          <group group_id="O3">
            <title>Postural Tachycardia Syndrome (POTS) Participants Who Consumed Low Sodium Diet.</title>
            <description>Patients with POTS were randomly assigned the order of dietary sodium levels with low sodium or high sodium diet starting after 1 day of 150 mEq sodium/day. All procedures were performed at both levels. Results below were after the low sodium diet. Urine was collected daily for a 24hr period ending at approximately 8am. These results are for the urine collection which ended on Day 5.</description>
          </group>
          <group group_id="O4">
            <title>Postural Tachycardia Syndrome (POTS) Participants Who Consumed High Sodium Diet</title>
            <description>Patients with POTS were randomly assigned the order of dietary sodium levels with low sodium or high sodium diet starting after 1 day of 150 mEq sodium/day. All procedures were performed at both levels. Results below were after the high sodium diet. Urine was collected daily for a 24hr period ending at approximately 8am. These results are for the urine collection which ended on Day 5.</description>
          </group>
        </group_list>
        <measure>
          <title>Urinary Dopamine Following Change in Dietary Sodium Days 4-5</title>
          <description>Urinary dopamine excretion will be measured every 24 hours as the participant adapts from the 150 mEq Na/day diet to the 10 and 300 mEq Na/day diets.</description>
          <population>Urine was collected and analyzed for 13 healthy controls and 14 patients with POTS during this time interval of the low sodium and high sodium diets</population>
          <units>micrograms</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
                <count group_id="O3" value="14"/>
                <count group_id="O4" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="213" lower_limit="145" upper_limit="253"/>
                    <measurement group_id="O2" value="202" lower_limit="150" upper_limit="261"/>
                    <measurement group_id="O3" value="205" lower_limit="145" upper_limit="257"/>
                    <measurement group_id="O4" value="214" lower_limit="189" upper_limit="280"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Urinary Dopamine Following Change in Dietary Sodium Days 5-6</title>
        <description>Urinary dopamine excretion will be measured every 24 hours as the participant adapts from the 150 mEq Na/day diet to the 10 and 300 mEq Na/day diets.</description>
        <time_frame>24 hour collections ending on Day 6 of each dietary sodium phase</time_frame>
        <population>Urine was collected and analyzed for 13 healthy controls and 14 patients with POTS during this time interval of the low sodium and high sodium diets</population>
        <group_list>
          <group group_id="O1">
            <title>Healthy Participants Who Consumed Low Sodium Diet as Intervention A or Intervention B</title>
            <description>Healthy controls were randomly assigned the order of dietary sodium levels with low sodium or high sodium diet starting after 1 day of 150 mEq sodium/day. All procedures were performed at both levels. Results below were after the low sodium diet. Urine was collected daily for a 24hr period ending at approximately 8am. These results are for the urine collection which ended on Day 6.</description>
          </group>
          <group group_id="O2">
            <title>Healthy Participants Who Consumed High Sodium Diet as Intervention A or Intervention B</title>
            <description>Healthy controls were randomly assigned the order of dietary sodium levels with low sodium or high sodium diet starting after 1 day of 150 mEq sodium/day. All procedures were performed at both levels. Results below were after the high sodium diet. Urine was collected daily for a 24hr period ending at approximately 8am. These results are for the urine collection which ended on Day 6.</description>
          </group>
          <group group_id="O3">
            <title>Postural Tachycardia Syndrome (POTS) Participants Who Consumed Low Sodium Diet.</title>
            <description>Patients with POTS were randomly assigned the order of dietary sodium levels with low sodium or high sodium diet starting after 1 day of 150 mEq sodium/day. All procedures were performed at both levels. Results below were after the low sodium diet. Urine was collected daily for a 24hr period ending at approximately 8am. These results are for the urine collection which ended on Day 6.</description>
          </group>
          <group group_id="O4">
            <title>Postural Tachycardia Syndrome (POTS) Participants Who Consumed High Sodium Diet</title>
            <description>Patients with POTS were randomly assigned the order of dietary sodium levels with low sodium or high sodium diet starting after 1 day of 150 mEq sodium/day. All procedures were performed at both levels. Results below were after the high sodium diet. Urine was collected daily for a 24hr period ending at approximately 8am. These results are for the urine collection which ended on Day 6.</description>
          </group>
        </group_list>
        <measure>
          <title>Urinary Dopamine Following Change in Dietary Sodium Days 5-6</title>
          <description>Urinary dopamine excretion will be measured every 24 hours as the participant adapts from the 150 mEq Na/day diet to the 10 and 300 mEq Na/day diets.</description>
          <population>Urine was collected and analyzed for 13 healthy controls and 14 patients with POTS during this time interval of the low sodium and high sodium diets</population>
          <units>micrograms</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
                <count group_id="O3" value="14"/>
                <count group_id="O4" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="227" lower_limit="160" upper_limit="258"/>
                    <measurement group_id="O2" value="210" lower_limit="169" upper_limit="263"/>
                    <measurement group_id="O3" value="211" lower_limit="156" upper_limit="263"/>
                    <measurement group_id="O4" value="199" lower_limit="168" upper_limit="251"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event data were collected through discharge on the last day of phase 2 of the study. This would have been Day 8 if Low Sodium diet or Day 7 if High Sodium diet.</time_frame>
      <desc>Adverse event information was collected for any untoward or unfavorable medical occurence in a participant including any abnormal sign, symptom, or disease, temporally associated with the participant's participation in the research, whether or not considered related to the participant's participation in the research. Events were self-reported by participants.</desc>
      <group_list>
        <group group_id="E1">
          <title>Healthy Participants Who Consumed Low Sodium Diet as Intervention A or Intervention B</title>
          <description>Healthy controls were randomly assigned the order of dietary sodium levels. All procedures were performed at both levels. Results below were after the low sodium diet.</description>
        </group>
        <group group_id="E2">
          <title>Healthy Participants Who Consumed High Sodium Diet as Intervention A or Intervention B</title>
          <description>Healthy controls were randomly assigned the order of dietary sodium levels. All procedures were performed at both levels. Results below were after the high sodium diet.</description>
        </group>
        <group group_id="E3">
          <title>Postural Tachycardia Syndrome (POTS) Participants Who Consumed Low Sodium Diet.</title>
          <description>Patients with POTS were randomly assigned the order of dietary sodium levels. All procedures were performed at both levels. Results below were after the low sodium diet.</description>
        </group>
        <group group_id="E4">
          <title>Postural Tachycardia Syndrome (POTS) Participants Who Consumed High Sodium Diet</title>
          <description>Patients with POTS were randomly assigned the order of dietary sodium levels. All procedures were performed at both levels. Results below were after the high sodium diet.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="13"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Mass</sub_title>
                <description>Participant notified the PI that a mass had been discovered on her pineal gland during a brain MRI for another research study. We do not believe that the mass is related to any study procedures undertaken as part of this research protocol.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="13"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Alfredo Gamboa MD</name_or_title>
      <organization>Vanderbilt University Medical Center</organization>
      <phone>6158751003</phone>
      <email>alfredo.gamboa@vumc.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

